NCT03342859 2021-01-06
Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned
Bayer
Phase 1 Terminated
Clinical Trials
4 trialsNCT03411980 2019-12-03
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
Bayer
Phase 1 Completed
NCT03092999 2017-08-18
Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)
Bayer
Phase 1 Completed
NCT01816815 2014-04-21
Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670
Bayer
Phase 1 Completed